Changes to Havrix booster dose

Changes to the prescribing information for the Havrix Monodose hepatitis A vaccine mean that it is no longer necessary to restart the primary vaccination schedule if the booster is administered within five years of primary vaccination.

Although a booster dose is normally recommended between six to 12 months of primary vaccination, it has been shown that immunocompetent subjects given a booster up to five years after initial vaccination can show a satisfactory antibody response sufficient for persistent immunity.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB11 1BT. Tel: (0800) 221441.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New antibiotic guidance for leg ulcer infection

New antibiotic guidance for leg ulcer infection

NICE has issued guidance on antibiotic choices and...

New insertion site for Nexplanon following safety concerns

New insertion site for Nexplanon following safety concerns

The MHRA has amended its advice relating to the long-acting...

Antibiotic Treatments in Adults, Summary of Regimens

Antibiotic Treatments in Adults, Summary of Regimens

Dose regimens for common bacterial infections.

Beta blocker overdose warning for GPs

Beta blocker overdose warning for GPs

The toxicity of a commonly prescribed beta blocker...